Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
Invasive Pulmonary Aspergillosis (IPA) and <i>Pneumocystis jiroveci</i> Pneumonia (PCP) are serious fungal pulmonary diseases for immunocompromised patients. The brand name drug CANCIDAS<sup>®</sup> (Caspofungin acetate for injection) is FDA approved to treat IPA, but is only...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Liburua |
| Argitaratua: |
MDPI AG,
2021-04-01T00:00:00Z.
|
| Gaiak: | |
| Sarrera elektronikoa: | Connect to this object online. |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Internet
Connect to this object online.3rd Floor Main Library
| Sailkapena: |
A1234.567 |
|---|---|
| Alea 1 | Eskuragarri |